BRG.AU

29.5

+3.04%↑

BRG.AU

29.5

+3.04%↑

BRG.AU

29.5

+3.04%↑

BRG.AU

29.5

+3.04%↑

BRG.AU

29.5

+3.04%↑

Search

Fisher & Paykel Healthcare Corp Ltd

Closed

SectorReal estate

33.77 0.12

Overview

Share price change

24h

Current

Min

33.42

Max

34.13

Key metrics

By Trading Economics

Income

224M

377M

Sales

329M

1.3B

P/E

Sector Avg

56.712

58.706

EPS

0.26

Dividend yield

1.15

Profit margin

29.462

Employees

7,384

EBITDA

379M

654M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+13.45% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

1.15%

5.81%

Market Stats

By TradingEconomics

Market Cap

-1.4B

20B

Previous open

33.65

Previous close

33.77

News Sentiment

By Acuity

45%

55%

52 / 190 Ranking in Real estate

Fisher & Paykel Healthcare Corp Ltd Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

28 maj 2025, 22:28 UTC

Market Talk

Fisher & Paykel Healthcare's Progress Attracts New Bull -- Market Talk

8 kwi 2025, 02:01 UTC

Market Talk

Tariff Impact on Fisher & Paykel Less Than Expected -- Market Talk

3 lut 2025, 21:55 UTC

Market Talk

F&P Healthcare Could Make More in New Zealand to Counter Tariff Impact -- Market Talk

2 lut 2025, 22:06 UTC

Market Talk

Fisher & Paykel Healthcare Slumps on Tariff Hit -- Market Talk

28 lis 2024, 21:55 UTC

Market Talk

F&P Healthcare Bear Sees Limited Scope for Guidance Upgrades -- Market Talk

18 lis 2024, 22:39 UTC

Market Talk

Sales Growth, Flu Season in Focus at F&P Healthcare's 1H Result -- Market Talk

2 wrz 2024, 23:56 UTC

Market Talk

Fisher & Paykel's Growth Outlook Looks Attractive -- Market Talk

Peer Comparison

Price change

Fisher & Paykel Healthcare Corp Ltd Forecast

Price Target

By TipRanks

13.45% upside

12 Months Forecast

Average 38.347 AUD  13.45%

High 42.1 AUD

Low 35.9 AUD

Based on 9 Wall Street analysts offering 12 month price targets forFisher & Paykel Healthcare Corp Ltd - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

9 ratings

5

Buy

4

Hold

0

Sell

Sentiment

By Acuity

52 / 190 Ranking in Real estate

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Fisher & Paykel Healthcare Corp Ltd

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products comprising humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, and humidifiers. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.